TeleDaaS Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations
Imaging Technology
NOVEMBER 26, 2023
“I anticipate that the benefit of radiopharmaceuticals will be maximized by combining radiopharmaceutical therapies with a vast array of other agents including immunotherapies, chemotherapeutics, radiosensitizers and radioprotectors. TeleDaaS licenses a cloud-based technology platform from Mirada Medical.
78 
Let's personalize your content